标题
Linking liver metabolic and vascular disease via bile acid signaling
作者
关键词
bile acid, non-alcoholic fatty liver disease (NAFLD), cardiovascular disease, FXR, GPBAR1
出版物
TRENDS IN MOLECULAR MEDICINE
Volume 28, Issue 1, Pages 51-66
出版商
Elsevier BV
发表日期
2021-11-21
DOI
10.1016/j.molmed.2021.10.005
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis
- (2021) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease
- (2021) Stefano Fiorucci et al. Expert Opinion on Drug Discovery
- Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease
- (2021) Sonja Lang et al. LIVER INTERNATIONAL
- Targeting inflammation in atherosclerosis — from experimental insights to the clinic
- (2021) Oliver Soehnlein et al. NATURE REVIEWS DRUG DISCOVERY
- Bile acids and their receptors in metabolic disorders
- (2021) Stefano Fiorucci et al. PROGRESS IN LIPID RESEARCH
- Muricholic Acids Promote Resistance to Hypercholesterolemia in Cholesterol-Fed Mice
- (2021) Dany Gaillard et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- Of mice and men: Murine bile acids explain species differences in the regulation of bile acid and cholesterol metabolism
- (2020) Sara Straniero et al. JOURNAL OF LIPID RESEARCH
- High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
- (2020) Katharina Lechner et al. Metabolic Syndrome and Related Disorders
- Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)
- (2020) Stefano Fiorucci et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- From NAFLD to MAFLD: Implications of a premature change in terminology
- (2020) Zobair M Younossi et al. HEPATOLOGY
- L-Arginine-Nitric Oxide-Asymmetric Dimethylarginine Pathway and the Coronary Circulation: Translation of Basic Science Results to Clinical Practice
- (2020) Attila Cziráki et al. Frontiers in Pharmacology
- Systematic review and meta-analysis of randomized controlled trials on the effects of obeticholic acid on the blood lipid profile: Insights into liver disorders and liver cancer
- (2020) Lin Guan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy
- (2020) Adriana Carino et al. FASEB JOURNAL
- The Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells
- (2020) Parth Trivedi et al. Cell Metabolism
- Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
- (2020) Rohit Loomba et al. HEPATOLOGY
- Nonalcoholic Fatty Liver Disease and the Incidence of Myocardial Infarction: A Cohort Study
- (2019) Dong Hyun Sinn et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients
- (2019) Paul J. Pockros et al. LIVER INTERNATIONAL
- Direct Amplification of Tissue Factor:Factor VIIa Procoagulant Activity by Bile Acids Drives Intrahepatic Coagulation
- (2019) Kevin S. Baker et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
- (2019) Myriam Alexander et al. BMJ-British Medical Journal
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
- (2019) Gordon I. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Bile acids in glucose metabolism in health and disease
- (2018) Hagit Shapiro et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Future trends in the treatment of non-alcoholic steatohepatitis
- (2018) Stefano Fiorucci et al. PHARMACOLOGICAL RESEARCH
- Burden of Illness and Economic Model for Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States
- (2018) Zobair M. Younossi et al. HEPATOLOGY
- Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis
- (2018) Adriana Carino et al. FASEB JOURNAL
- Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption
- (2018) Young-Chae Kim et al. GASTROENTEROLOGY
- Homocysteine Modification in Protein Structure/Function and Human Disease
- (2018) Hieronim Jakubowski PHYSIOLOGICAL REVIEWS
- Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
- (2017) Harald Staiger et al. ENDOCRINE REVIEWS
- Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice
- (2017) Jan Freark de Boer et al. GASTROENTEROLOGY
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
- (2017) Chris Estes et al. HEPATOLOGY
- Bi-directional analysis between fatty liver and cardiovascular disease risk factors
- (2017) Jiantao Ma et al. JOURNAL OF HEPATOLOGY
- Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance
- (2017) Manuel Lasalle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans
- (2017) Panu K. Luukkonen et al. THROMBOSIS AND HAEMOSTASIS
- BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis
- (2017) Adriana Carino et al. Scientific Reports
- Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis
- (2017) Sabrina Cipriani et al. Scientific Reports
- Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice
- (2017) Adriana Carino et al. Scientific Reports
- An Intestinal Farnesoid X Receptor–Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice
- (2016) Cen Xie et al. DIABETES
- Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype?
- (2016) R. J. Hodge et al. DIABETES OBESITY & METABOLISM
- An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
- (2016) Frank J. Gonzalez et al. GASTROENTEROLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Preserved hemostatic status in patients with non-alcoholic fatty liver disease
- (2016) Wilma Potze et al. JOURNAL OF HEPATOLOGY
- Regulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted state
- (2016) Dandan Guan et al. Journal of Translational Medicine
- A new frontier in FGF21 biology
- (2016) Matthew J. Potthoff Nature Reviews Endocrinology
- Metabolic fibroblast growth factors (FGFs): Mediators of energy homeostasis
- (2016) Kathleen R. Markan et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Mechanism and Regulation of NLRP3 Inflammasome Activation
- (2016) Yuan He et al. TRENDS IN BIOCHEMICAL SCIENCES
- Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids
- (2015) Barbara Renga et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Nonalcoholic Fatty Liver Disease and Vascular Function: Cross-Sectional Analysis in the Framingham Heart Study
- (2015) M. T. Long et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Discovery of Intestinal Targeted TGR5 Agonists for the Treatment of Type 2 Diabetes
- (2015) Hongliang Duan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Leptin in nonalcoholic fatty liver disease: A narrative review
- (2015) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases
- (2015) Fangfang Zhang et al. MOLECULAR ENDOCRINOLOGY
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
- (2015) Sungsoon Fang et al. NATURE MEDICINE
- Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders
- (2015) Stefano Fiorucci et al. TRENDS IN MOLECULAR MEDICINE
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1
- (2015) Barbara Renga et al. PLoS One
- 4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists
- (2014) Qingan Zou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
- (2014) Ffolliott M. Fisher et al. GASTROENTEROLOGY
- Procoagulant imbalance in patients with non-alcoholic fatty liver disease
- (2014) Armando Tripodi et al. JOURNAL OF HEPATOLOGY
- Design, Synthesis, and Biological Evaluation of Potent Dual Agonists of Nuclear and Membrane Bile Acid Receptors
- (2014) Claudio D’Amore et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploitation of Cholane Scaffold for the Discovery of Potent and Selective Farnesoid X Receptor (FXR) and G-Protein Coupled Bile Acid Receptor 1 (GP-BAR1) Ligands
- (2014) Carmen Festa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual Activation of the Bile Acid Nuclear Receptor FXR and G-Protein-Coupled Receptor TGR5 Protects Mice against Atherosclerosis
- (2014) Shinobu Miyazaki-Anzai et al. PLoS One
- Bile Acid Receptor TGR5 Agonism Induces NO Production and Reduces Monocyte Adhesion in Vascular Endothelial Cells
- (2013) Taiki Kida et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis
- (2013) Andrew Paul DeFilippis et al. ATHEROSCLEROSIS
- Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis
- (2013) Priya Handa et al. HEPATOLOGY
- Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells
- (2012) Divya P. Kumar et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Ceramide-Centric View of Insulin Resistance
- (2012) Jose A. Chavez et al. Cell Metabolism
- 2-Phenoxy-nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5)
- (2012) Rainer E. Martin et al. ChemMedChem
- Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21
- (2012) Holly A. Cyphert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dual actions of fibroblast growth factor 19 on lipid metabolism
- (2012) Xinle Wu et al. JOURNAL OF LIPID RESEARCH
- Design, Synthesis, and Antidiabetic Activity of 4-Phenoxynicotinamide and 4-Phenoxypyrimidine-5-carboxamide Derivatives as Potent and Orally Efficacious TGR5 Agonists
- (2012) Hongliang Duan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
- (2012) Anna C. Calkin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Farnesoid X Receptor Agonist for the Treatment of Liver and Metabolic Disorders: Focus on 6-ethyl-CDCA
- (2011) S. Fiorucci et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
- (2011) Zeneng Wang et al. NATURE
- FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
- (2011) S. Kir et al. SCIENCE
- The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance
- (2010) Tim C. M. A. Schreuder et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- A Role of the Bile Salt Receptor FXR in Atherosclerosis
- (2010) Jurre Hageman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain
- (2010) Verena Keitel et al. GLIA
- Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease
- (2010) Luca Valenti et al. HEPATOLOGY
- Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice
- (2010) Galya Vassileva et al. JOURNAL OF ENDOCRINOLOGY
- Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
- (2010) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
- (2010) Klementina Fon Tacer et al. MOLECULAR ENDOCRINOLOGY
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- The Bile Acid Sensor FXR Protects against Dyslipidemia and Aortic Plaques Development Induced by the HIV Protease Inhibitor Ritonavir in Mice
- (2010) Andrea Mencarelli et al. PLoS One
- A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia
- (2009) Mark J. Evans et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders
- (2009) Verena Keitel et al. HEPATOLOGY
- Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
- (2009) Sushant Bhatnagar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glucose stimulates cholesterol 7α-hydroxylase gene transcription in human hepatocytes
- (2009) Tiangang Li et al. JOURNAL OF LIPID RESEARCH
- Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism
- (2009) Mary-Elizabeth Patti et al. Obesity
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
- (2009) E. Fabbrini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bile acid-activated receptors in the treatment of dyslipidemia and related disorders
- (2009) Stefano Fiorucci et al. PROGRESS IN LIPID RESEARCH
- Antiatherosclerotic effect of farnesoid X receptor
- (2008) Andrea Mencarelli et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Expression and function of the bile acid receptor TGR5 in Kupffer cells
- (2008) Verena Keitel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Selective versus Total Insulin Resistance: A Pathogenic Paradox
- (2008) Michael S. Brown et al. Cell Metabolism
- Liver, Muscle, and Adipose Tissue Insulin Action Is Directly Related to Intrahepatic Triglyceride Content in Obese Subjects
- (2008) Kevin M. Korenblat et al. GASTROENTEROLOGY
- Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression
- (2008) Kwang-Hoon Song et al. HEPATOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
- Endocrine and paracrine role of bile acids
- (2008) Verena Keitel et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now